Davina Lau

857 total citations
7 papers, 664 citations indexed

About

Davina Lau is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Davina Lau has authored 7 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Davina Lau's work include Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). Davina Lau is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). Davina Lau collaborates with scholars based in Canada, United States and India. Davina Lau's co-authors include Ming‐Sound Tsao, Chang‐Qi Zhu, Frances A. Shepherd, Ni Liu, Melania Pintilie, Sarit Aviel‐Ronen, Timothy Winton, Suzanne K. Lau, Keyue Ding and Akira Sakurada and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Davina Lau

7 papers receiving 647 citations

Peers

Davina Lau
Muaiad Kittaneh United States
Wilma J. Teubel Netherlands
Nerissa Mendoza United States
P.N. Munster United States
Austin Dulak United States
Muaiad Kittaneh United States
Davina Lau
Citations per year, relative to Davina Lau Davina Lau (= 1×) peers Muaiad Kittaneh

Countries citing papers authored by Davina Lau

Since Specialization
Citations

This map shows the geographic impact of Davina Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davina Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davina Lau more than expected).

Fields of papers citing papers by Davina Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davina Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davina Lau. The network helps show where Davina Lau may publish in the future.

Co-authorship network of co-authors of Davina Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Davina Lau. A scholar is included among the top collaborators of Davina Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davina Lau. Davina Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Navab, Roya, Jiang Liu, Isolde Seiden‐Long, et al.. (2009). Co-overexpression of Met and Hepatocyte Growth Factor Promotes Systemic Metastasis in NCI-H460 Non-Small Cell Lung Carcinoma Cells. Neoplasia. 11(12). 1292–IN6. 62 indexed citations
2.
Aviel‐Ronen, Sarit, Suzanne K. Lau, Melania Pintilie, et al.. (2008). Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Modern Pathology. 21(7). 817–825. 83 indexed citations
3.
Lau, Suzanne K., Paul C. Boutros, Melania Pintilie, et al.. (2007). Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(35). 5562–5569. 189 indexed citations
4.
Aviel‐Ronen, Sarit, Melania Pintilie, Davina Lau, Serge Jothy, & Ming‐Sound Tsao. (2007). Does Glypican 3 expression in non-small cell lung cancer suggest an oncogenic function?. Cancer Research. 67. 187–187. 1 indexed citations
5.
Tsao, Ming‐Sound, Sarit Aviel‐Ronen, Keyue Ding, et al.. (2007). Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(33). 5240–5247. 256 indexed citations
6.
Zhu, Chang‐Qi, Fiona Blackhall, Melania Pintilie, et al.. (2004). Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker. Clinical Cancer Research. 10(6). 1984–1991. 72 indexed citations
7.
Lau, Davina, David R. Gandara, Ji‐Kan Ryu, et al.. (1997). 282 Phase I trial of concurrent irradiation and bi-weekly paclitaxel for stage III non-small-cell lung cancer. Lung Cancer. 18. 74–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026